Heming Li
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 24
- Cancer Cells and Metastasis 9
- Cancer Immunotherapy and Biomarkers 5
- Inflammatory Biomarkers in Disease Prognosis 4
- Co-authors
- Mingfang Zhao (11 shared papers)Yunpeng Liu (8 shared papers)Xiujuan Qu (7 shared papers)Ling Xu (6 shared papers)Izhar Singh Batth (7 shared papers)Ruoyu Wang (5 shared papers)Shulin Li (5 shared papers)Hyangsoon Noh (5 shared papers)
- Journals
- Cancer Letters (4 papers)PLoS ONE (3 papers)Journal of Controlled Release (2 papers)Molecular Cancer (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Heming Li
58 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 95
- Cancer Research 271
- Oncology 426
- Molecular Biology 456
- Immunology 128
- Pharmaceutical Science 36
Countries citing papers authored by Heming Li
This map shows the geographic impact of Heming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heming Li more than expected).
Fields of papers citing papers by Heming Li
This network shows the impact of papers produced by Heming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heming Li. The network helps show where Heming Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Heming Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 116 | |
| 2 | 2017 | 90 | |
| 3 | 2021 | 88 | |
| 4 | 2014 | 73 | |
| 5 | 2003 | 70 | |
| 6 | 2022 | 65 | |
| 7 | 2022 | 61 | |
| 8 | 2020 | 44 | |
| 9 | 2012 | 42 | |
| 10 | 2014 | 38 | |
| 11 | 2014 | 34 | |
| 12 | 2017 | 28 | |
| 13 | 2024 | 26 | |
| 14 | 2020 | 25 | |
| 15 | 2017 | 25 | |
| 16 | 2023 | 21 | |
| 17 | 2017 | 21 | |
| 18 | 2014 | 21 | |
| 19 | 2019 | 20 | |
| 20 | 2016 | 20 |
About Heming Li
Heming Li is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Immunology, having authored 62 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (9 papers), Cancer-related molecular mechanisms research (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (4 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), Ferroptosis and cancer prognosis (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (271 citations), Oncology (426 citations), Molecular Biology (456 citations), Immunology (128 citations) and Pharmaceutical Science (36 citations). Heming Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Mingfang Zhao, Yunpeng Liu, Xiujuan Qu, Ling Xu, Izhar Singh Batth, Ruoyu Wang, Shulin Li, Hyangsoon Noh, Qing H. Meng and Shaobing Zhou. Their work appears in journals such as Cancer Letters, PLoS ONE, Journal of Controlled Release, Molecular Cancer and Journal of Experimental & Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.